{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:21:46Z","timestamp":1761862906618},"reference-count":20,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ijpharm.2010.06.042","type":"journal-article","created":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T04:51:34Z","timestamp":1277959894000},"page":"44-49","source":"Crossref","is-referenced-by-count":17,"title":["Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres"],"prefix":"10.1016","volume":"397","author":[{"given":"Fengying","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesheng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2010.06.042_bib1","first-page":"528","article-title":"Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs","volume":"26","author":"Andersson","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0939-6411(98)00011-3","article-title":"Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants","volume":"45","author":"Blanco","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0009-9236(98)90104-7","article-title":"Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamics of tolterodine","volume":"63","author":"Brynne","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1365-2125.1999.00053.x","article-title":"Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity","volume":"48","author":"Brynne","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1248\/cpb.55.625","article-title":"Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice","volume":"55","author":"Chu","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijpharm.2004.10.016","article-title":"Mucoadhesive microspheres prepared by interpolymer complexation and solvent diffusion method","volume":"288","author":"Chun","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0090-4295(00)01020-7","article-title":"Advancements in pharmacologic management of the overactive bladder","volume":"56","author":"Dmochowski","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ijpharm.2010.06.042_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1208\/pt060470","article-title":"A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres","volume":"6","author":"D'Souza","year":"2005","journal-title":"Pharm. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11095-005-9042-6","article-title":"Effect of polymer blending on the release of ganciclovir from PLGA microspheres","volume":"23","author":"Duvvuri","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/3-540-45734-8_3","article-title":"Degradable polymer microspheres for controlled drug delivery","volume":"157","author":"Edlund","year":"2002","journal-title":"Adv. Polym. Sci."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib11","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1016\/j.biomaterials.2005.02.025","article-title":"Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting","volume":"26","author":"Fahmy","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2010.06.042_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(71)90082-3","article-title":"Brain levels of imipramine and desipramine after combined treatment with these drugs in rats","volume":"15","author":"Jori","year":"1971","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0090-4295(02)01535-2","article-title":"Effect of muscarinic antagonists on micturition pressure measured by cystometry in normal, conscious rats","volume":"59","author":"Modiri","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.ijpharm.2010.06.042_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0168-3659(01)00280-2","article-title":"Evaluation of in vivo release characteristics of proteined-loaded biodegradable microspheres in rats and severe combined immunodeficiency disease mice","volume":"73","author":"Morita","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2010.06.042_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0024-3205(97)00057-X","article-title":"Tolterodine-a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data","volume":"60","author":"Nilvebrant","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-409X(97)00049-5","article-title":"Preparation of microspheres by the solvent evaporation technique","volume":"28","author":"O\u2019Donnell","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1248\/cpb.57.1251","article-title":"Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(d,l-lactide-co-glycolide) microsphere","volume":"57","author":"Su","year":"2009","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/js970047r","article-title":"Drug microencapsulation by PLA\/PLGA coacervation in the light of thermodynamics","volume":"87","author":"Thomasin","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(01)00649-4","article-title":"Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies","volume":"220","author":"Yen","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2010.06.042_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jconrel.2008.01.004","article-title":"Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres","volume":"127","author":"Zolnik","year":"2008","journal-title":"J. Control. Release"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517310004709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517310004709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T22:20:25Z","timestamp":1544394025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517310004709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":20,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0378517310004709"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2010.06.042","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}